CN109874780A - 渗透性保护剂、无血清冻存液以及该无血清冻存液的制备与使用方法 - Google Patents
渗透性保护剂、无血清冻存液以及该无血清冻存液的制备与使用方法 Download PDFInfo
- Publication number
- CN109874780A CN109874780A CN201910175354.2A CN201910175354A CN109874780A CN 109874780 A CN109874780 A CN 109874780A CN 201910175354 A CN201910175354 A CN 201910175354A CN 109874780 A CN109874780 A CN 109874780A
- Authority
- CN
- China
- Prior art keywords
- serum
- stock solution
- frozen stock
- cell
- free
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000011550 stock solution Substances 0.000 title claims abstract description 43
- 230000035699 permeability Effects 0.000 title claims abstract description 18
- 239000003223 protective agent Substances 0.000 title claims abstract description 15
- 238000000034 method Methods 0.000 title claims abstract description 9
- 238000002360 preparation method Methods 0.000 title claims abstract description 8
- PUKLDDOGISCFCP-JSQCKWNTSA-N 21-Deoxycortisone Chemical group C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)C)(O)[C@@]1(C)CC2=O PUKLDDOGISCFCP-JSQCKWNTSA-N 0.000 claims abstract description 11
- FCYKAQOGGFGCMD-UHFFFAOYSA-N Fulvic acid Natural products O1C2=CC(O)=C(O)C(C(O)=O)=C2C(=O)C2=C1CC(C)(O)OC2 FCYKAQOGGFGCMD-UHFFFAOYSA-N 0.000 claims abstract description 11
- 229940095100 fulvic acid Drugs 0.000 claims abstract description 11
- 239000002509 fulvic acid Substances 0.000 claims abstract description 11
- 239000000243 solution Substances 0.000 claims abstract description 11
- 238000005138 cryopreservation Methods 0.000 claims description 33
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 28
- 239000007788 liquid Substances 0.000 claims description 23
- 239000012679 serum free medium Substances 0.000 claims description 16
- 229910052757 nitrogen Inorganic materials 0.000 claims description 14
- 239000006285 cell suspension Substances 0.000 claims description 12
- 230000009467 reduction Effects 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 230000001954 sterilising effect Effects 0.000 claims description 6
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 claims description 4
- 239000007640 basal medium Substances 0.000 claims description 4
- 210000004369 blood Anatomy 0.000 claims description 4
- 239000008280 blood Substances 0.000 claims description 4
- UZOVYGYOLBIAJR-UHFFFAOYSA-N 4-isocyanato-4'-methyldiphenylmethane Chemical compound C1=CC(C)=CC=C1CC1=CC=C(N=C=O)C=C1 UZOVYGYOLBIAJR-UHFFFAOYSA-N 0.000 claims description 2
- 108091006905 Human Serum Albumin Proteins 0.000 claims description 2
- 102000008100 Human Serum Albumin Human genes 0.000 claims description 2
- 239000012980 RPMI-1640 medium Substances 0.000 claims description 2
- 125000002252 acyl group Chemical group 0.000 claims description 2
- 239000001963 growth medium Substances 0.000 claims description 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 2
- 238000011084 recovery Methods 0.000 abstract description 7
- 230000004083 survival effect Effects 0.000 abstract description 6
- 230000000694 effects Effects 0.000 abstract description 4
- 210000004027 cell Anatomy 0.000 description 45
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 20
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 238000005057 refrigeration Methods 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000012202 endocytosis Effects 0.000 description 2
- 239000012894 fetal calf serum Substances 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 description 2
- 210000000130 stem cell Anatomy 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- -1 Acyl serine Chemical compound 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 102000002070 Transferrins Human genes 0.000 description 1
- 108010015865 Transferrins Proteins 0.000 description 1
- GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 210000005056 cell body Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000000254 damaging effect Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- GPOMTENHXXIXEG-UHFFFAOYSA-N ethyl(2-hydroxyethyl)azanium;chloride Chemical compound Cl.CCNCCO GPOMTENHXXIXEG-UHFFFAOYSA-N 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 210000003714 granulocyte Anatomy 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 229940054269 sodium pyruvate Drugs 0.000 description 1
- 229960001471 sodium selenite Drugs 0.000 description 1
- 235000015921 sodium selenite Nutrition 0.000 description 1
- 239000011781 sodium selenite Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910175354.2A CN109874780A (zh) | 2019-03-08 | 2019-03-08 | 渗透性保护剂、无血清冻存液以及该无血清冻存液的制备与使用方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910175354.2A CN109874780A (zh) | 2019-03-08 | 2019-03-08 | 渗透性保护剂、无血清冻存液以及该无血清冻存液的制备与使用方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109874780A true CN109874780A (zh) | 2019-06-14 |
Family
ID=66931421
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910175354.2A Pending CN109874780A (zh) | 2019-03-08 | 2019-03-08 | 渗透性保护剂、无血清冻存液以及该无血清冻存液的制备与使用方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109874780A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110583622A (zh) * | 2019-08-30 | 2019-12-20 | 依科赛生物科技(太仓)有限公司 | 一种t细胞无血清冻存液及其使用方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH11292701A (ja) * | 1998-04-03 | 1999-10-26 | Shimizu Pharmaceutical Co Ltd | 細胞保護液 |
CN101310009A (zh) * | 2005-11-17 | 2008-11-19 | 日本全药工业株式会社 | 细胞保存用水溶液 |
CN108707579A (zh) * | 2018-05-28 | 2018-10-26 | 北京美迪阿姆科技发展有限公司 | 一种人t淋巴细胞培养用的无血清培养基及制备方法和培养方法 |
CN108782544A (zh) * | 2018-06-28 | 2018-11-13 | 吉林省拓华生物科技有限公司 | 一种大量冻存间充质干细胞的冻存液及方法 |
CN109221082A (zh) * | 2018-09-14 | 2019-01-18 | 上海慧存医疗科技有限公司 | 细胞冻存液、冻存复苏方法及其应用 |
-
2019
- 2019-03-08 CN CN201910175354.2A patent/CN109874780A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH11292701A (ja) * | 1998-04-03 | 1999-10-26 | Shimizu Pharmaceutical Co Ltd | 細胞保護液 |
CN101310009A (zh) * | 2005-11-17 | 2008-11-19 | 日本全药工业株式会社 | 细胞保存用水溶液 |
CN108707579A (zh) * | 2018-05-28 | 2018-10-26 | 北京美迪阿姆科技发展有限公司 | 一种人t淋巴细胞培养用的无血清培养基及制备方法和培养方法 |
CN108782544A (zh) * | 2018-06-28 | 2018-11-13 | 吉林省拓华生物科技有限公司 | 一种大量冻存间充质干细胞的冻存液及方法 |
CN109221082A (zh) * | 2018-09-14 | 2019-01-18 | 上海慧存医疗科技有限公司 | 细胞冻存液、冻存复苏方法及其应用 |
Non-Patent Citations (1)
Title |
---|
YU XIAO 等: ""Effects of fulvic acids on goat sperm"", 《ZYGOTE》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110583622A (zh) * | 2019-08-30 | 2019-12-20 | 依科赛生物科技(太仓)有限公司 | 一种t细胞无血清冻存液及其使用方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105685016B (zh) | 细胞冻存保护组合物、该组合物的用途以及细胞冻存的方法 | |
CN107027743B (zh) | 细胞冻存液及细胞冻存方法 | |
CN104663649B (zh) | 人类卵母细胞冷冻保护剂 | |
CN109090100A (zh) | 一种间充质干细胞冻存液及其制备方法与使用方法 | |
WO2005052138A1 (en) | Cryopreservation of pluripotent stem cells | |
CN107094753A (zh) | 一种造血干细胞冻存液及造血干细胞冻存方法 | |
CN112889813B (zh) | 一种细胞存活率高的人脐带间充质干细胞的冻存方法 | |
CN111183972A (zh) | 一种组合物及其应用和一种精子冷冻液及其制备方法 | |
CN108235981A (zh) | 一种可临床使用的细胞冻存液 | |
CN111149795A (zh) | 一种冷冻保护剂及其应用和一种精子冷冻液及其制备方法 | |
CN108450458A (zh) | 一种无血清细胞冻存液 | |
WO2000019817A1 (en) | Cell preconditioning and cryopreservation medium | |
CN105211052B (zh) | 一种培养后的nkt细胞的冻存液及其制备方法 | |
CN109619088A (zh) | 一种脂肪间充质干细胞的保存液 | |
CN110024775A (zh) | 临床细胞制剂用保存液的配方和用途 | |
JP6073794B2 (ja) | 培養膵島 | |
CN109874780A (zh) | 渗透性保护剂、无血清冻存液以及该无血清冻存液的制备与使用方法 | |
Quan et al. | Oocyte cryopreservation based in sheep: The current status and future perspective | |
CN108902129A (zh) | 细胞冻存组合物及其应用 | |
CN109329272A (zh) | 一种精子冻存液及其制备方法和应用 | |
CN103719071B (zh) | 一种大口黑鲈精子超低温冷冻保存及复苏方法 | |
WO2008127959A1 (en) | Ergothioneine and/or its derivatives as a cell preservative | |
WO2015026307A1 (en) | Boron added cell cryopreservation medium | |
BR112013001191B1 (pt) | Método ex vivo para isolamento de ilhotas de pâncreas de tecido pancreático | |
CN106993605A (zh) | 一种绒山羊冷冻精液稀释液配方 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20240220 Address after: Room 305, Building 3, No. 88 Kechuang 6th Street, Beijing Economic and Technological Development Zone, Tongzhou District, Beijing, 100176 Applicant after: Beijing Kangda Xingjian Technology Development Co.,Ltd. Country or region after: China Address before: 100000 b217, floor 2, building B, No. 18, West Ring South Road, Beijing Economic and Technological Development Zone, Beijing Applicant before: BEIJING MEIDI AMU TECHNOLOGY DEVELOPMENT Co.,Ltd. Country or region before: China |